January 27, 2014 Synthetic Biologics Strengthens Clinical & Regulatory Team to Support Expanding Pipeline of Infectious Disease Programs
January 8, 2014 Synthetic Biologics to Present at the 7th Annual OneMedForum San Francisco 2014 Conference
December 9, 2013 Synthetic Biologics and Intrexon Corporation Initiate Development of Novel Biologics for a Subset of Patients Suffering from Irritable Bowel Syndrome (IBS)
